Clinical Trials Browser

Phase 3 × Thalidomide × Genitourinary × Clear all

NCT00004635 2018-05-22

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

Phase 3 Completed

159 enrolled 9 charts

Neoplasms, Prostatic Neoplasms

NCT00005966 2009-02-05

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms